Paydirt
SEPN
Ticker

Septerna, Inc.

SEPN · Healthcare · Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule produc…

Septerna, Inc. (SEPN), in the Healthcare sector, has 9 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 0 purchases and 9 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Oct 15 and filed Oct 19. The most active filer was Elizabeth Bhatt with 3 filings. Data as of Nov 7 2026.

Add to watchlist
Filings, ttm
9
0 buys · 9 sells
Traders, ttm
4
4 insiders
Volume, ttmiDollar value disclosed in the window
$68.0M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Oct 15
Filed Oct 19
ADViAverage daily dollar volume
$19.2M
market data
Share price · 12M
$41.38 (+128.6%)
$48.19$33.14$18.10Nov 10 2025May 5Oct 26

Adjusted for splits and dividends.

Volume by month
$64.6M$32.3M$0Dec 2024Jun 2025Dec 2025Jun 2026Feb 2025 · buys $6.3MMar 2025 · buys $468KMar 2026 · sells $2.0MMay 2026 · sells $355KJun 2026 · sells $752KJul 2026 · sells $136KAug 2026 · sells $64.6MSep 2026 · sells $126KOct 2026 · sells $109K
Buys $6.7M Sells $68.0M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed · past 24 months
EB Elizabeth Bhatt President and COO 3 filings · 0 buys, 3 sales SS Samira Shaikhly Chief People Officer 3 filings · 0 buys, 3 sales DL Daniel D. Long SVP, Drug Discovery 2 filings · 0 buys, 2 sales TL Third Rock Ventures GP V, LP 10% owner 2 filings · 2 buys, 0 sales AE Alan Ezekowitz Director 1 filing · 1 buy, 0 sales RP Ra Capital Management, L.P. Director 1 filing · 0 buys, 1 sale
Recent filings
Elizabeth BhattSALE President and COO $109K
2,906 sh × $37.61
Exec Oct 15
Filed Oct 19 · 7:00 PM ET
Daniel D. LongSALE SVP, Drug Discovery $126K
3,333 sh × $37.83
Exec Sep 1
Filed Sep 3 · 7:01 PM ET
Ra Capital Management, L.P.SALE Director $63.5M
1,493,000 sh across 2 lots
Exec Aug 12
Filed Aug 14 · 5:11 PM ET
Elizabeth BhattSALE President and COO $1.1M
25,000 sh × $44.00
Exec Aug 11
Filed Aug 13 · 7:00 PM ET
Elizabeth BhattSALE President and COO $136K
4,000 sh × $33.99
Exec Jul 15
Filed Jul 17 · 7:00 PM ET
Daniel D. LongSALE SVP, Drug Discovery $533K
15,000 sh across 2 lots
Exec Jun 22
Filed Jun 24 · 5:30 PM ET
Samira ShaikhlySALE Chief People Officer $219K
6,250 sh × $35.08
Exec Jun 12
Filed Jun 16 · 5:30 PM ET
Samira ShaikhlySALE Chief People Officer $355K
11,798 sh × $30.06
Exec May 26
Filed May 28 · 5:30 PM ET
Samira ShaikhlySALE Chief People Officer $2.0M
70,453 sh across 2 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET
Alan EzekowitzPURCHASE Director $468K
79,190 sh across 2 lots
Exec Mar 5 2025
Filed Mar 6 2025 · 5:30 PM ET
Third Rock Ventures GP V, LPPURCHASE 10% owner $113K
18,861 sh × $6.00
Exec Feb 24 2025
Filed Feb 26 2025 · 5:30 PM ET
Third Rock Ventures GP V, LPPURCHASE 10% owner $6.2M
1,040,342 sh across 2 lots
Exec Feb 20 2025
Filed Feb 24 2025 · 5:30 PM ET
Rajeev M. ShahPURCHASE Director $75.1M
4,170,000 sh across 2 lots
Exec Oct 28 2024
Filed Oct 30 2024 · 5:30 PM ET
Trv Gp V, LlcPURCHASE 10% owner $11.7M
650,000 sh across 2 lots
Exec Oct 28 2024
Filed Oct 28 2024 · 5:30 PM ET